天美传媒

ISSN: 2161-119X

Otolaryngology: 天美传媒 Access
天美传媒 Access

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 天美传媒 Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

天美传媒 Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Research Article   
  • Otolaryngol (Sunnyvale) 2015, Vol 5(4): 196
  • DOI: 10.4172/2161-119X.1000196

A Pilot Study of Induction Triplet Chemotherapy Followed by Minimally Invasive Surgery for Stage 3-4 Resectable Oropharyngeal Cancer

Krishna Rao1,2,3,4*, Kathy Robinson4, James Malone4,5, Cathy Clausen6, Bruce Shevlin6 and K Thomas Robbins4,5
1Department of Internal Medicine, Southern Illinois University School of Medicine, USA
2Division of Hematology/Oncology, Department of Internal Medicine, Southern Illinois University School of Medicine, USA
3Department of Medical Microbiology, Southern Illinois University School of Medicine, USA
4Simmons Cancer Institute at SIU, Southern Illinois University School of Medicine, USA
5Division of Otolaryngology Head and Neck Surgery, Department of Surgery, Southern Illinois University School of Medicine, USA
6St. John’s Hospital Department of Radiation Oncology, Springfield, IL, Southern Illinois University School of Medicine, USA
*Corresponding Author : Krishna Rao, Simmons Cancer Institute at Southern Illinois University School of Medicine, 315 W. Carpenter St., PO Box 19678, Springfield, IL 62794-9678, USA, Tel: 2175457045, Fax: 2175457021, Email: krao@siumed.edu

Received Date: Apr 10, 2015 / Accepted Date: May 19, 2015 / Published Date: May 26, 2015

Abstract

The current study reports the results of an open label pilot study evaluating a novel treatment protocol for patients with locally advanced head and neck cancer. Patients received induction chemotherapy and those who had a clinical complete response to induction chemotherapy were offered trans-oral nidusectomy for the primary lesion and neck node dissection. If a pathologic complete response was achieved, patients were then observed. Patients not achieving a clinical or pathologic complete response to induction therapy were subsequently treated with chemoradiation.

Keywords: Induction, Head and neck cancer, Chemotherapy

Citation: Rao K, Robinson K, Malone J, Clausen C, Shevlin B, et al (2015) A Pilot Study of Induction Triplet Chemotherapy Followed by Minimally Invasive Surgery for Stage 3-4 Resectable Oropharyngeal Cancer . Otolaryngol (Sunnyvale) 5: 196. Doi: 10.4172/2161-119X.1000196

Copyright: © 2015 Rao K, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

International Conferences 2025-26
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top